Low-level vancomycin resistance in Staphylococcus aureus—an Australian perspective

被引：0
作者：
B. P. Howden
P. B. Ward
P. D. R. Johnson
P. G. P. Charles
M. L. Grayson
机构：
[1] Austin Health,Infectious Diseases Department
[2] Austin Health,Microbiology Department
[3] Monash University,Present address: Microbiology Department
来源：
European Journal of Clinical Microbiology and Infectious Diseases | 2005年 / 24卷
关键词：
Vancomycin; Glycopeptide; Linezolid; Fusidic Acid; Brain Heart Infusion Agar;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Low-level vancomycin resistance in Staphylococcus aureus has emerged as a clinical problem over the past 8 years. The clinical relevance of this resistance has been questioned, and laboratory detection remains difficult and time consuming. There is, however, increasing evidence linking low-level vancomycin resistance with glycopeptide treatment failure in serious Staphylococcus aureus infections. Diagnostic laboratories and clinicians need to be aware of this resistance phenotype, to have procedures in place to detect the resistance, and to have strategies for managing patients with infections caused by resistant strains.
引用
收藏
页码：100 / 108
页数：8
相关论文
共 50 条
[41]   Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus [J].
Rishishwar, Lavanya ;
Kraft, Colleen S. ;
King Jordan, I. .
MSPHERE, 2016, 1 (04)
[42]   Genomic Organization of a Vancomycin-Resistant Staphylococcus aureus [J].
Mirani, Zulfiqar Ali ;
Jamil, Nusrat .
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (02) :107-111
[43]   Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in Staphylococcus aureus [J].
Chavva, Hasitha ;
Meka, Yogesh ;
Long, Timothy E. E. .
FRONTIERS IN MICROBIOLOGY, 2023, 13
[44]   Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus [J].
Chaudhary, Bajarangi Lal ;
Bisht, Dakshina ;
Faujdar, Sameer .
ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) :16-20
[45]   Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini hospital in Tehran [J].
Aligholi, Marzieh ;
Emaneini, Mohammad ;
Jabalameli, Fereshteh ;
Shahsavan, Shadi ;
Dabiri, Hosein ;
Sedaght, Hossein .
MEDICAL PRINCIPLES AND PRACTICE, 2008, 17 (05) :432-434
[46]   Impact of sigB mutation on Staphylococcus aureus oxacillin and vancomycin resistance varies with parental background and method of assessment [J].
Singh, VK ;
Schmidt, JL ;
Jayaswal, RK ;
Wilkinson, BJ .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (03) :256-261
[47]   Vancomycin and linezolid resistance among multidrug-resistant Staphylococcus aureus clinical isolates and interaction with neutrophils [J].
Al-Bdery, Alaa Shahid Jassim ;
Mohammad, Ghaidaa Jihadi ;
Hussen, Bashdar .
GENE REPORTS, 2020, 21
[48]   In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin:: does vancomycin resistance occur? [J].
Kleinschmidt, SL ;
Munckhof, WJ ;
Nimmo, GR .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (02) :168-170
[49]   Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model [J].
Dilworth, Thomas J. ;
Leonard, Steve N. ;
Vilay, A. Mary ;
Mercier, Renee-Claude .
CLINICAL THERAPEUTICS, 2014, 36 (10) :1334-1344
[50]   The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC [J].
Chen, Hongbin ;
Liu, Yudong ;
Sun, Wenjia ;
Chen, Minjun ;
Wang, Hui .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (03) :301-303
12345